The size of the Latin American stem cell assay market is estimated to be growing at a CAGR of 20.1% during the forecast period. The market is estimated to value USD 281.64 million by 2026 from USD 112.71 million in 2021.
Stem cell analyzes are the research procedures followed in laboratory research and have become more and more necessary as stem cell research has developed. In addition, these tests are used in the search for new drugs and other industrial research. Therefore, the increase in chorionic diseases and stem cell testing in the research and development of new therapies and drug development increase the market growth during the forecast period.
MARKET DRIVERS:
Over the past decade, the application of cell-based assays has grown at a rapid rate among research institutes and pharmaceutical industries. The growth of the Latin American stem cell assay market matches that of the biotechnology and biopharmaceutical industries as they are the major end-users of stem cell research products. The continuation of this trend, the growth of the end-user base, has forced several companies to launch new products and invest in stem cell therapies.
With the increase in clinical trial approvals for stem cell therapy, the high prevalence of chronic diseases, and the increase in activities related to stem cell research and technological advancements in assay methods, stem cells complement the growing of the Latin American stem cell assay market. The increase in the evolution of new technologies and the increase in the patient group provide opportunities for the global market growth during the forecast period. Stem cells have the potential to treat a wide range of health disorders.
Major investments in the field and scope of medical biotechnology are expected to drive the growth of the stem cell analysis market during the forecast period. Regenerative medicine helps natural healing processes work faster and more efficiently.
MARKET RESTRAINTS:
To control these activities, ethical authorities and the government have formulated strict regulations. The presence of these ethical concerns and restrictions on the use of cells for research severely limits cell biology research in many countries worldwide. This, in turn, is expected to restrain the growth of the stem cell assay market. In addition, market growth may be hampered due to the huge cost of stem cell assay equipment such as Immune assays for diseases such as diabetes, which use bio regeneration therapy. These restrain the growth of the market during the projected period 2020-2026.
The lack of professionals trained to analyze stem cells, the high cost of stem cell-based instruments and therapies, and strict intellectual property rights challenge the market for stem cell analysis.
This research report on the Latin America Stem Cell Assay Market has been segmented and sub-segmented into the following categories:
By Assay Type:
By Kits:
By Application:
By End User:
By Country:
Based on region, developing countries like Brazil and Argentina with huge patient bases provide many opportunities for the expansion of companies in this region. Brazil holds the largest market share due to the growing awareness of stem cell testing and the availability of many market players. Other countries such as Colombia, Argentina, etc., will also experience healthy growth due to the increase in population and chronic diseases such as cancer, cardiovascular disorders, and others. In addition, increased funding from the government and the private sector boosts the market in different parts of the world.
KEY MARKET PLAYERS:
Some of the notable companies operating in the Latin America Stem Cell Assay Market profiled in the report are Thermo Fisher Scientific Inc., Bio-Techne Corporation, Stem cell Technologies Inc., Merck KGaA, Promega Corporation, GE Healthcare, Bio-Rad Laboratories, Inc., Cellular Dynamics International Inc., Hemogenix, and Cell Biolabs Inc.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Assay Type
5.1.1 Introduction
5.1.2 Cell Viability & Toxicity Assays
5.1.3 Cell Identification Assays
5.1.4 Cell Differentiation Assays
5.1.5 Isolation/Purification Assays
5.1.6 Cell Proliferation Assays
5.1.7 Cell Apoptosis Assays
5.1.8 Cell Function Assays
5.1.9 Y-o-Y Growth Analysis, By Assay Type
5.1.10 Market Attractiveness Analysis, By Assay Type
5.1.11 Market Share Analysis, By Assay Type
5.2 Technology
5.2.1 Introduction
5.2.2 Technology Roadmap
5.2.3 Micro Fabricated Assisted Technology
5.2.3.1 Microfluidics Based Cell Trap Technologies
5.2.4 Technology in Development
5.2.5 Y-o-Y Growth Analysis, By Technology
5.2.6 Market Attractiveness Analysis, By Technology
5.2.7 Market Share Analysis, By Technology
5.3 Kits
5.3.1 Introduction
5.3.2 Adult Stem Cell Kits
5.3.2.1 Induced Pluripotent Stem Cell Kits
5.3.2.2 Mesenchymal Stem Cell Kits
5.3.2.3 Neuronal Stem Cells Kits
5.3.2.4 Umbilical Cord Stem Cells
5.3.2.5 Hematopoietic Stem Cell Kits
5.3.3 Human Embryonic Stem Cells Kits
5.3.4 Y-o-Y Growth Analysis, By Kits
5.3.5 Market Attractiveness Analysis, By Kits
5.3.6 Market Share Analysis, By Kits
5.4 Product
5.4.1 Introduction
5.4.2 Instruments
5.4.2.1 Micro Electrode Arrays
5.4.2.2 Cell Imaging Systems
5.4.2.3 Automated Cell Counter
5.4.2.4 Flow Cytometer
5.4.3 Detection Kits
5.4.3.1 Immuno Histochemistry Kits
5.4.4 Y-o-Y Growth Analysis, By Product
5.4.5 Market Attractiveness Analysis, By Product
5.4.6 Market Share Analysis, By Product
5.5 Application
5.5.1 Introduction
5.5.2 Regenerative Medicine & Therapy Development
5.5.2.1 Orthopedic & Musculoskeletal Spine
5.5.2.2 Central Nervous System
5.5.2.3 Dermatology
5.5.2.4 Cardiovascular
5.5.2.5 Diabetes
5.5.2.6 Oncology
5.5.2.7 Others
5.5.3 Drug Discovery and Development
5.5.4 Clinical Research
5.6 End User
5.6.1 Introduction
5.6.2 Research Institutes
5.6.3 Industry Research
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Assay Type
6.1.3.3 By Technology
6.1.3.4 By Kits
6.1.3.5 By Product
6.1.3.6 By Application
6.1.3.7 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Assay Type
6.1.4.3 By Technology
6.1.4.4 By Kits
6.1.4.5 By Product
6.1.4.6 By Application
6.1.4.7 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Assay Type
6.1.5.3 By Technology
6.1.5.4 By Kits
6.1.5.5 By Product
6.1.5.6 By Application
6.1.5.7 By End User
6.2 Brazil
6.3 Mexico
6.4 Rest of Latin America
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Thermo Fisher Scientific Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Bio-Techne Corporation
8.3 STEMCELL Technologies Inc.
8.4 Promega Corporation
8.5 GE Healthcare
8.6 Bio-Rad Laboratories, Inc.
8.7 Merck KGaA
8.8 Cellular Dynamics International Inc.
8.9 Hemogenix
8.10 Cell Biolabs Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
